From Backyard Gardens to National Impact: How One Detroit Native is Leading the Fight Against Climate Change
23 avr. 2024 14h52 HE
|
AmeriCorps
Detroit, Mich, April 23, 2024 (GLOBE NEWSWIRE) -- In a speech delivered ahead of an appearance by President Joe Biden, Detroit native, AmeriCorps member and environmental champion, Za’Nyia Kelly,...
Biden-Harris Administration Announces Major Steps to Stand Up Landmark American Climate Corps Initiative, Mobilizing the Next Generation of Climate Leaders
22 avr. 2024 16h08 HE
|
AmeriCorps
Washington, DC, April 22, 2024 (GLOBE NEWSWIRE) -- As part of the Biden-Harris administration’s historic climate and environmental justice agenda, President Biden will announce today a suite of key...
HeartFlow Initiates DECIDE Registry to Evaluate Utility of HeartFlow AI-Enabled Plaque Analysis for Patients with Suspected Coronary Artery Disease
26 mars 2024 14h00 HE
|
HeartFlow Holding, Inc.
MOUNTAIN VIEW, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the leader in AI-driven healthcare technology, today announced the launch of the DECIDE Registry, the largest prospective...
Biden-Harris Administration Announces New Agreement Between Seven Federal Agencies to Implement the American Climate Corps
19 déc. 2023 13h30 HE
|
AmeriCorps
Washington, DC, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Today, the Biden-Harris administration is taking critical steps to advance the American Climate Corps, a landmark initiative announced by President...
Cardiometabolic Health Congress Hosts 2023 Women's Masterclass in California
29 juin 2023 11h00 HE
|
Cardiometabolic Health Congress
Boca Raton, FL, June 29, 2023 (GLOBE NEWSWIRE) -- Informed by topics most relevant to cardiometabolic health providers, medical education leader Cardiometabolic Health Congress (CMHC) has announced...
Global Advanced Driver Assistance Systems (ADAS) Market Size/Share Worth USD 81.17 Billion by 2032 at an 18.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
05 juin 2023 16h30 HE
|
Custom Market Insights
Austin, TX, USA, June 05, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Advanced Driver Assistance Systems (ADAS) Market Size, Trends and Insights By...
Elevar Therapeutics to Present Clinically Supported Poster at AACR 2023 Demonstrating Rivoceranib as a Potent, and Most Selective, TKI for VEGFR-2
16 mars 2023 08h00 HE
|
Elevar Therapeutics
FORT LEE, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...
CLEAR Outcomes Accepted as Late-Breaking Clinical Trial at ACC.23 Annual Scientific Session & Expo together with the World Congress of Cardiology (ACC.23/WCC)
19 déc. 2022 16h15 HE
|
Esperion Therapeutics, Inc.
– Positive CLEAR Outcomes data to be presented as a Late-Breaking Clinical Trial (LBCT) at ACC.23/WCC on March 4, 2023 – – Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral...
QuisLex Fall Schedule to Feature In-Person and Virtual Events
08 sept. 2022 09h16 HE
|
QuisLex
Calendar of forums and conferences includes speaking engagements and sponsorships of premier events including SOLID, CLOC, ACC and Consero legal forums NEW YORK, Sept. 08, 2022 (GLOBE NEWSWIRE) --...
Esperion Announces Bempedoic Acid (NEXLETOL®) Recommended as Oral Non-Statin Therapy for LDL-Cholesterol Lowering in American College of Cardiology Expert Consensus Decision Pathway
26 août 2022 08h16 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that bempedoic acid (NEXLETOL®) is now recommended as an important oral non-statin therapy for...